Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,887,242
-
Total 13F shares
-
2,000,189
-
Share change
-
-82,856
-
Total reported value
-
$5,500,414
-
Price per share
-
$2.75
-
Number of holders
-
21
-
Value change
-
-$431,314
-
Number of buys
-
5
-
Number of sells
-
9
Institutional Holders of Aprea Therapeutics, Inc. - Common Stock (APRE) as of Q3 2024
As of 30 Sep 2024 Aprea Therapeutics, Inc. - Common Stock (APRE) had 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,000,189 shares of stock of the company.
Largest 10 holders included AIGH Capital Management LLC, Sio Capital Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Stonepine Capital Management, LLC, DAFNA Capital Management LLC, Exome Asset Management LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This table shows 21 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.